Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate

The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, di...

Full description

Bibliographic Details
Main Authors: Kim Munk, Lise Gormsen, Won Yong Kim, Niels Holmark Andersen
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Case Reports in Pediatrics
Online Access:http://dx.doi.org/10.1155/2015/905097
id doaj-cdcf0ff1ac9f48e0b61ba623a1be13e8
record_format Article
spelling doaj-cdcf0ff1ac9f48e0b61ba623a1be13e82020-11-25T00:11:57ZengHindawi LimitedCase Reports in Pediatrics2090-68032090-68112015-01-01201510.1155/2015/905097905097Cardiac Arrest following a Myocardial Infarction in a Child Treated with MethylphenidateKim Munk0Lise Gormsen1Won Yong Kim2Niels Holmark Andersen3Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, DenmarkDepartment of Psychiatry, Aarhus University Hospital, Risskov Skovagervej 2, 8240 Risskov, DenmarkDepartment of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, DenmarkDepartment of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, DenmarkThe use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, did not report any cases of myocardial infarction in current users of methylphenidate, and the risk of serious adverse cardiac events was not found to be increased. We present a case with an 11-year-old child, treated with methylphenidate, who suffered cardiac arrest and was diagnosed with a remote myocardial infarction. This demonstrates that myocardial infarction can happen due to methylphenidate exposure in a cardiac healthy child, without cardiovascular risk factors.http://dx.doi.org/10.1155/2015/905097
collection DOAJ
language English
format Article
sources DOAJ
author Kim Munk
Lise Gormsen
Won Yong Kim
Niels Holmark Andersen
spellingShingle Kim Munk
Lise Gormsen
Won Yong Kim
Niels Holmark Andersen
Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
Case Reports in Pediatrics
author_facet Kim Munk
Lise Gormsen
Won Yong Kim
Niels Holmark Andersen
author_sort Kim Munk
title Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
title_short Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
title_full Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
title_fullStr Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
title_full_unstemmed Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
title_sort cardiac arrest following a myocardial infarction in a child treated with methylphenidate
publisher Hindawi Limited
series Case Reports in Pediatrics
issn 2090-6803
2090-6811
publishDate 2015-01-01
description The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, did not report any cases of myocardial infarction in current users of methylphenidate, and the risk of serious adverse cardiac events was not found to be increased. We present a case with an 11-year-old child, treated with methylphenidate, who suffered cardiac arrest and was diagnosed with a remote myocardial infarction. This demonstrates that myocardial infarction can happen due to methylphenidate exposure in a cardiac healthy child, without cardiovascular risk factors.
url http://dx.doi.org/10.1155/2015/905097
work_keys_str_mv AT kimmunk cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate
AT lisegormsen cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate
AT wonyongkim cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate
AT nielsholmarkandersen cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate
_version_ 1725402175881871360